WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines.
Arciniega
J L
JL
Center for Biologics Evaluation and Research, Rockville, MD, USA.
Corbel
M
M
Dellepiane
N
N
Dobbelaer
R
R
Griffiths
E
E
Heron
I
I
Ivanoff
B
B
Kreeftenberg
H
H
Mastrantonio
P
P
Meade
B
B
Milstein
J
J
Robertson
S
S
Robinson
A
A
Sato
H
H
Sato
Y
Y
Schwanig
M
M
Tiru
M
M
D000818:Animals; D000942:Antigens, Bacterial / Q000032:analysis; D001886:Bordetella pertussis / Q000276:immunology; D004355:Drug Stability; D006801:Humans; D010567:Pertussis Vaccine / Q000096:biosynthesis* / Q000592:standards* / Q000633:toxicity; D011786:Quality Control; D012015:Reference Standards; D017778:Vaccines, Combined / Q000096:biosynthesis / Q000592:standards / Q000633:toxicity
D000942:Antigens, Bacterial; D010567:Pertussis Vaccine; D017778:Vaccines, Combined